Hair repigmentation associated with the use of brentuximab

Lauren R Penzi; Athena Manatis-Lornell; Arturo Saavedra; David Fisher; Maryanne M Senna

doi:10.1016/j.jdcr.2017.09.027

Hair repigmentation associated with the use of brentuximab

JAAD Case Rep. 2017 Nov 8;3(6):563-565. doi: 10.1016/j.jdcr.2017.09.027. eCollection 2017 Nov.

Authors

Lauren R Penzi¹, Athena Manatis-Lornell¹, Arturo Saavedra², David Fisher^{1

3}, Maryanne M Senna^{1

3}

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
² University of Virginia School of Medicine, Charlottesville, Virginia.
³ Harvard Medical School, Boston, Massachusetts.

No abstract available

Keywords: IL, interleukin; TNF, tumor necrosis factor; aging; antibody-drug conjugate; brentuximab; cGVHD, chronic graft versus host disease; graying; hair follicle; hair repigmentation; melanocyte.

Publication types

Case Reports